Heron Therapeutics (HRTX)
NASDAQ:HRTX
Holding HRTX?
Track your performance easily

Heron Therapeutics (HRTX) Financial Statements

1,502 Followers

Heron Therapeutics Financial Overview

Heron Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.325; its P/E ratio is -5.47; Heron Therapeutics is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 36.02M$ 34.67M$ 34.23M$ 31.43M$ 31.76M
Gross Profit$ 25.51M$ 26.23M$ 24.35M$ 13.23M$ 11.60M
EBIT$ -9.23M$ -3.16M$ -6.30M$ -25.01M$ -42.06M
EBITDA$ -7.81M$ -2.97M$ -5.58M$ -24.55M$ -41.63M
Net Income Common Stockholders$ -9.23M$ -3.16M$ -10.72M$ -25.01M$ -42.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 67.35M$ 71.52M$ 80.41M$ 77.41M$ 33.24M
Total Assets$ 218.14M$ 217.89M$ 222.51M$ 229.20M$ 201.22M
Total Debt$ 178.71M$ 179.17M$ 155.37M$ 155.97M$ 156.13M
Net Debt$ 111.36M$ 107.65M$ 74.96M$ 78.56M$ 122.88M
Total Liabilities$ 256.08M$ 251.65M$ 256.48M$ 256.99M$ 240.51M
Stockholders Equity$ -37.94M$ -33.77M$ -33.97M$ -27.79M$ -39.28M
Cash Flow-
Free Cash Flow$ -5.24M$ -9.52M$ 2.22M$ -9.97M$ -27.41M
Operating Cash Flow$ -4.60M$ -9.52M$ 2.46M$ -9.18M$ -27.13M
Investing Cash Flow$ 2.05M$ 1.28M$ -8.84M$ -23.22M$ 13.22M
Financing Cash Flow$ 492.00K$ 11.00K$ 199.00K$ 53.80M$ 319.00K
Currency in USD

Heron Therapeutics Earnings and Revenue History

Heron Therapeutics Debt to Assets

Heron Therapeutics Cash Flow

Heron Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis